Compare NVS & MRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVS | MRVL |
|---|---|---|
| Founded | 1895 | 1995 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.0B | 235.4B |
| IPO Year | 2001 | 2020 |
| Metric | NVS | MRVL |
|---|---|---|
| Price | $151.01 | $227.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 46 |
| Target Price | $154.65 | ★ $339.36 |
| AVG Volume (30 Days) | 1.5M | ★ 15.6M |
| Earning Date | 10-27-2026 | 12-01-2026 |
| Dividend Yield | ★ 1.97% | 0.11% |
| EPS Growth | N/A | ★ 400.98 |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $8,194,600,000.00 |
| Revenue This Year | $1.73 | $47.29 |
| Revenue Next Year | $6.39 | $63.21 |
| P/E Ratio | ★ $23.13 | $587.84 |
| Revenue Growth | N/A | ★ 42.09 |
| 52 Week Low | $121.57 | $70.69 |
| 52 Week High | $170.46 | $329.88 |
| Indicator | NVS | MRVL |
|---|---|---|
| Relative Strength Index (RSI) | 56.65 | 41.19 |
| Support Level | $149.30 | $155.66 |
| Resistance Level | $155.26 | $248.24 |
| Average True Range (ATR) | 2.26 | 16.42 |
| MACD | 1.29 | -5.44 |
| Stochastic Oscillator | 64.67 | 9.76 |
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.